IBM Is an AI and IT Leader Set for Growth, Says Analyst. Plus, Lowe’s, Rocket, and More Stocks.

Get the latest analysis on Cognition Therapeutics (CGTX): risks, funding outlook, and zervimesine’s potential in Alzheimer’s ...

Corporate representation at COP30 has sharply declined since the 2021 Glasgow summit, replacing high-profile marketing stunts ...

B. Riley raised the firm’s price target on Zymeworks (ZYME) to $40 from $30 and keeps a Buy rating on the shares. Zymeworks’ shift to a royalty-aggregation strategy aims to optimize future de-risked ...

Utah's Minor Protection in Social Media Act requires social media platforms to take extra care with minor users. But a ...

The global geothermal power market is projected to reach $14.5 billion by 2034, driven by its high-capacity baseload power, ...

The Cyprus Securities and Exchange Commission (CySEC) said the listed websites — including fernrise.com, market-trading.ltd, ...

Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...

The China-aligned advanced persistent threat (APT) tracked as 'PlushDaemon' is hijacking software update traffic to deliver ...

Silence Therapeutics advanced its RNAi drug for polycythemia vera, shared new Phase 2 trial updates, and reaffirmed a strong ...

A loud boom has been heard throughout Jefferson County over the last couple of months. Those who have heard it say it usually ...